Advance care planning in stroke: influence of time on engagement in the process

Por Green, Theresa, Gandhi, Shreyas, Kleissen, Tessa, Simon, Jessica, Raffin-Bouchal, Shelley, Ryckborst, Karla
Publicado em 2014

The Beta-hCG + Erythropoietin in Acute Stroke (BETAS) study A three center, single dose, open label, non-controlled, Phase IIa safety trial

Por Cramer, Steven C., Fitzpatrick, Camille, Warren, Michael, Hill, Michael D., Brown, David, Whitaker, Laura, Ryckborst, Karla J., Plon, Lawrence
Publicado em 2010

The Albumin in Acute Stroke (ALIAS) Part 1 Trial: An exploratory efficacy analysis

Por Hill, Michael D., Martin, Renee, Palesch, Yuko, Tamariz, Diego, Ryckborst, Karla J., Moy, Claudia S., Barsan, William G., Ginsberg, Myron D.
Publicado em 2011

Prolonged Activation of Invariant Natural Killer T Cells and T(H)2-Skewed Immunity in Stroke Patients

Por Wong, Connie H. Y., Jenne, Craig N., Tam, Patrick P., Léger, Caroline, Venegas, Andres, Ryckborst, Karla, Hill, Michael D., Kubes, Paul
Publicado no Front Neurol (2017)

THE ALBUMIN IN ACUTE STROKE (ALIAS) MULTICENTER CLINICAL TRIAL: SAFETY ANALYSIS OF PART 1, AND RATIONALE AND DESIGN OF PART 2

Por Ginsberg, Myron D., Palesch, Yuko Y., Martin, Renee H., Hill, Michael D., Moy, Claudia S., Waldman, Bonnie D., Yeatts, Sharon D., Tamariz, Diego, Ryckborst, Karla
Publicado em 2010

High-dose albumin treatment for acute ischaemic stroke (ALIAS): a phase 3, randomised, double-blind, placebo-controlled trial

Por Ginsberg, Myron D., Palesch, Yuko Y., Hill, Michael D., Martin, Renee H., Moy, Claudia S., Barsan, William G., Waldman, Bonnie D., Tamariz, Diego, Ryckborst, Karla J.
Publicado em 2013

Albumin Administration in Acute Ischemic Stroke: Safety Analysis of the ALIAS Part 2 Multicenter Trial

Por Hill, Michael D., Martin, Renee H., Palesch, Yuko Y., Moy, Claudia S., Tamariz, Diego, Ryckborst, Karla J., Jones, Elizabeth B., Weisman, David, Pettigrew, Creed, Ginsberg, Myron D.
Publicado no PLoS One (2015)

Methodology of the Interventional Management of Stroke (IMS) III Trial

Por Khatri, Pooja, Hill, Michael D., Palesch, Yuko Y., Spilker, Judith, Jauch, Edward C., Carrozzella, Janice A., Demchuk, Andrew M., Martin, Renee’, Mauldin, Patrick, Dillon, Catherine, Ryckborst, Karla J., Janis, Scott, Tomsick, Thomas A, Broderick, Joseph P
Publicado em 2008

Improving reperfusion time within the ESCAPE Endovascular Clinical Trial

Por Kamal, Noreen, Smith, Eric E, Menon, Bijoy K, Eesa, Muneer, Ryckborst, Karla J, Poppe, Alexandre Y, Roy, Daniel, Thornton, John, Williams, David, Casaubon, Leanne K, Silver, Frank L, Butcher, Kenneth, Shuaib, Ashfaq, Rempel, Jeremy L, Jovin, Tudor G, Sapkota, Biggya L, Demchuk, Andrew M, Goyal, Mayank, Hill, Michael D
Publicado no Eur Stroke J (2016)

Twelve-month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial

Por Palesch, Yuko Y., Yeatts, Sharon D., Tomsick, Thomas A, Foster, Lydia D., Demchuk, Andrew M., Khatri, Pooja, Hill, Michael D., Jauch, Edward C., Jovin, Tudor G., Yan, Bernard, von Kummer, Rüdiger, Molina, Carlos A., Goyal, Mayank, Schonewille, Wouter J., Mazighi, Mikael, Engelter, Stefan T., Anderson, Craig, Spilker, Judith, Carrozzella, Janice, Ryckborst, Karla J., Janis, L. Scott, Simpson, Annie, Simpson, Kit N., Broderick, Joseph P.
Publicado no Stroke (2015)

Observed Cost and Variations in Short Term Cost‐Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III

Por Simpson, Kit N., Simpson, Annie N., Mauldin, Patrick D., Palesch, Yuko Y., Yeatts, Sharon D., Kleindorfer, Dawn, Tomsick, Thomas A., Foster, Lydia D., Demchuk, Andrew M., Khatri, Pooja, Hill, Michael D., Jauch, Edward C., Jovin, Tudor G., Yan, Bernard, von Kummer, Rüdiger, Molina, Carlos A., Goyal, Mayank, Schonewille, Wouter J., Mazighi, Mikael, Engelter, Stefan T., Anderson, Craig, Spilker, Judith, Carrozzella, Janice, Ryckborst, Karla J., Janis, L. Scott, Broderick, Joseph P.
Publicado no J Am Heart Assoc (2017)

Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke

Por Broderick, Joseph P., Palesch, Yuko Y., Demchuk, Andrew M., Yeatts, Sharon D., Khatri, Pooja, Hill, Michael D., Jauch, Edward C., Jovin, Tudor G., Yan, Bernard, Silver, Frank L., von Kummer, Rüdiger, Molina, Carlos A., Demaerschalk, Bart M., Budzik, Ronald, Clark, Wayne M., Zaidat, Osama O., Malisch, Tim W., Goyal, Mayank, Schonewille, Wouter J., Mazighi, Mikael, Engelter, Stefan T., Anderson, Craig, Spilker, Judith, Carrozzella, Janice, Ryckborst, Karla J., Janis, L. Scott, Martin, Renée H., Foster, Lydia D., Tomsick, Thomas A.
Publicado em 2013

Endovascular Therapy is Effective and Safe for Patients with Severe Ischemic Stroke: Pooled Analysis of IMS III and MR CLEAN Data

Por Broderick, Joseph P., Berkhemer, Olvert A., Palesch, Yuko Y., Dippel, Diederik W.J., Foster, Lydia D., Roos, Yvo B.W.E.M., van der Lugt, Aad, Tomsick, Thomas A., Majoie, Charles B.L.M., van Zwam, Wim H., Demchuk, Andrew M., van Oostenbrugge, Robert J., Khatri, Pooja, Lingsma, Hester F., Hill, Michael D., Roozenbeek, Bob, Jauch, Edward C., Jovin, Tudor G., Yan, Bernard, von Kummer, Rüdiger, Molina, Carlos A., Goyal, Mayank, Schonewille, Wouter J., Mazighi, Mikael, Engelter, Stefan T., Anderson, Craig S., Spilker, Judith, Carrozzella, Janice, Ryckborst, Karla J., Janis, L. Scott, Simpson, Kit
Publicado no Stroke (2015)